Soleno Therapeutics
SLNO
SLNO
22 hedge funds and large institutions have $5.23M invested in Soleno Therapeutics in 2022 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 13 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
77% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 13
86% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 21
Holders
22
Holding in Top 10
–
Calls
$37K
Puts
$24K
Top Buyers
| 1 | +$243K | |
| 2 | +$110K | |
| 3 | +$20.2K | |
| 4 |
Morgan Stanley
New York
|
+$1.58K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$1.51K |
Top Sellers
| 1 | -$394K | |
| 2 | -$60.7K | |
| 3 | -$55K | |
| 4 |
Two Sigma Advisers
New York
|
-$43K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$35.6K |